AFP
GSK icon

Ausdal Financial Partners’s GSK GSK Stock Holding History

Ausdal Financial Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
4,197
-144
-3% -$7.62K 0.01% 950
2026
Q1 		$240K Buy
+4,341
New +$235K 0.01% 868
2016
Q1 		– Sell
-637
Closed -$32K – 552
2015
Q4 		$32K Buy
+637
New +$32.5K 0.02% 581

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ausdal Financial Partners's GSK Position: Q2 2026 in Review

Ausdal Financial Partners reduced its GSK (GSK) stake by 3.3% in Q2 2026, selling an estimated $7.62K and leaving 4,197 shares worth $220K. The position accounts for 0.01% of the portfolio, ranked #950.

Ausdal Financial Partners first reported a position in GSK in Q4 2015 and has held it in 3 quarters since. The position peaked at $240K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ausdal Financial Partners held 4,197 shares of GSK worth $220K as of Q2 2026.
  • Ausdal Financial Partners sold 144 GSK shares in Q2 2026, an estimated $7.62K.
  • GSK made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #950 holding.
  • Ausdal Financial Partners first reported a position in GSK in Q4 2015 and has held it in 3 quarters since.
  • Ausdal Financial Partners's GSK position peaked at $240K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.